An evaluation of clinical stability criteria to predict hospital course in community-acquired pneumonia.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Clinical Microbiology and Infection

• Publication date

  2013-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/1469-0691.12173PMID 23438068
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• British Thoracic Society Standards of Care Committee

  2014cited by this paper
• Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia--a propensity-adjusted analysis.

  2011cited by this paper
• Safety and efficacy of CURB65-guided antibiotic therapy in community-acquired pneumonia.

  2011cited by this paper
• Validation of the Infectious Diseases Society of America/American Thoratic Society minor criteria for intensive care unit admission in community-acquired pneumonia patients without major criteria or contraindications to intensive care unit care.

  2011cited by this paper
• Association between time to clinical stability and outcomes after discharge in hospitalized patients with community-acquired pneumonia.

  2011cited by this paper
• Predicting mortality with severity assessment tools in out-patients with community-acquired pneumonia.

  2011cited by this paper
• Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial.

  2010cited by this paper
• Predictive accuracy of the pneumonia severity index vs CRB-65 for time to clinical stability: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study.

  2010cited by this paper
• Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis

  2010cited by this paper
• Stability in community-acquired pneumonia: one step forward with markers?

  2009cited by this paper
• Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia

  2009cited by this paper
• Systolic blood pressure is superior to other haemodynamic predictors of outcome in community acquired pneumonia

  2008cited by this paper
• Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia.

  2008cited by this paper
• C-reactive protein is an independent predictor of severity in community-acquired pneumonia.

  2008cited by this paper
• Predicting the need for mechanical ventilation and/or inotropic support for young adults admitted to the hospital with community-acquired pneumonia.

  2008cited by this paper
• Pneumonia: criteria for patient instability on hospital discharge.

  2008cited by this paper
• Increasing Hospital Admissions for Pneumonia, England

  2008cited by this paper
• Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course

  2007cited by this paper
• Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

  2007cited by this paper
• Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study

  2006cited by this paper
• Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study

  2003cited by this paper
• Instability on hospital discharge and the risk of adverse outcomes in patients with pneumonia.

  2002cited by this paper
• BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

  2001cited by this paper
• Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines.

  1998cited by this paper
• A prediction rule to identify low-risk patients with community-acquired pneumonia.

  1997cited by this paper
• Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia.

  1995cited by this paper
• Utility of C-reactive protein measurements for empyema diagnosis after pneumonectomy.

  1994cited by this paper
• A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

  1983cited by this paper
• Index for rating diagnostic tests

  1950cited by this paper
• Efficacy of Corticosteroids in Community-acquired Pneumonia a Randomized Double-blinded Clinical Trial at a Glance Commentary

  year unknowncited by this paper

• Predictive Factors for Invasive Mechanical Ventilation in Community-acquired Pneumonia

  2025cites this paper
• Management of community-acquired pneumonia in immunocompetent adults: updated Swedish guidelines

  2025cites this paper
• Time to Clinical Stability Among Pediatric Patients With Severe Pneumonia: Southwest Ethiopia: Prospective Follow-Up Study

  2025cites this paper
• Treatment Failure and Clinical Stability in Severe Community-Acquired Pneumonia

  2024cites this paper
• A clinical prediction model for safe early discharge of patients with an infection at the emergency department.

  2024cites this paper
• Reassessing Halm's clinical stability criteria in community-acquired pneumonia management

  2024cites this paper
• Patients with Hemophagocytic Lymphohistiocytosis Who Need Intensive Care Can Be Successfully Rescued by Timely Using Etoposide-Based HLH Regimens

  2024cites this paper
• Community-Acquired Pneumonia in the Immunocompromised Patients: An Observational Study from a Single Center, TURKEY

  2024cites this paper
• Risk factors for complicated community-acquired pneumonia course in patients treated with β-lactam monotherapy.

  2021cites this paper
• Development and Internal Validation of a Model Predicting Safe, Early Discharge Among Patients Presenting to the Emergency Department with an Infection.

  2020cites this paper
• Markov State Modelling of Disease Courses and Mortality Risks of Patients with Community-Acquired Pneumonia

  2020cites this paper
• Relationship Between the Serum Level of C-Reactive Protein and Severity and Outcomes of Community-acquired Pneumonia

  2019cites this paper
• Sequential organ failure assessment score is an excellent operationalization of disease severity of adult patients with hospitalized community acquired pneumonia – results from the prospective observational PROGRESS study

  2019influential citation
• [Immunocompetent adults hospitalized for a community-acquired pneumonia: Serum C-reactive protein as a prognostic marker].

  2019cites this paper
• Management of Community-Acquired Pneumonia in Adults

  2018cites this paper
• INVITED REVIEW SERIES: RESPIRATORY INFECTIONS IN THE ASIA-PACIFIC REGION

  2018cites this paper
• Management of community-acquired pneumonia in immunocompetent adults: updated Swedish guidelines 2017

  2018cites this paper
• Tools for outcome prediction in patients with community acquired pneumonia

  2017cites this paper
• Oral versus intravenous clarithromycin in moderate to severe community-acquired pneumonia: an observational study

  2017cites this paper
• Predictors of treatment failure and clinical stability in patients with community acquired pneumonia.

  2017influential citation
• Individual and health system variation in rehospitalizations the year after pneumonia

  2017cites this paper
• Factors associated with early treatment failure in adult hospitalized patients with community-acquired pneumonia

  2017cites this paper
• Diagnostic Dilemma in the Routine Diagnosis of Non-Resolving Pneumonia in Elderly Patients: a Cross-sectional Study

  2017cites this paper
• Predictors and Implications of Early Clinical Stability in Patients Hospitalized for Moderately Severe Community-Acquired Pneumonia

  2016cites this paper
• Risk factors for Clostridium difficile infection in hospitalized patients with community-acquired pneumonia.

  2016cites this paper
• Expression of B and T Lymphocyte Attenuator in Patients with Severe Community-Acquired Pneumonia and the Effect of Steroid Therapy in a Mouse Model.

  2016cites this paper
• Role of fiberoptic bronchoscopy and BAL in assessment of the patients with non-responding pneumonia

  2016cites this paper
• Plasma levels of soluble intercellular adhesion molecule-1 as a biomarker for disease severity of patients with community-acquired pneumonia.

  2016cites this paper
• Predicting 2‐Year Risk of Developing Pneumonia in Older Adults without Dementia

  2016influential citation
• Corticosteroids for community-acquired pneumonia: a critical view of the evidence

  2016cites this paper
• Vital Signs Are Still Vital: Instability on Discharge and the Risk of Post-Discharge Adverse Outcomes

  2016cites this paper
• The Modern Diagnostic Approach to Community-Acquired Pneumonia in Adults

  2016cites this paper
• Neumonía adquirida en la comunidad

  2015cites this paper
• Community-acquired pneumonia.

  2015cites this paper
• Empirical Antibiotic Treatment for Community-acquired Pneumonia: New Perspectives

  2015cites this paper
• Parapneumonic effusions: epidemiology and predictors of pleural infection

  2014cites this paper
• Predictors and impact of time to clinical stability in community-acquired pneumococcal pneumonia.

  2014cites this paper
• Acute Pneumonia

  2014cites this paper
• Severity assessment scores to guide empirical use of antibiotics in community acquired pneumonia.

  2013cites this paper
• Community-acquired pneumonia

  2013cites this paper